@patrickching yes!!

🆕AASLD guidance for HCC screening

➡️Ultrasound + AFP q6months

✔️Cirrhosis (any etiology, including HCV post-SVR)
✔️Non-cirrhotic HBV:
-Man from endemic country >40y
-Woman '' >50y
-Person from Africa at earlier age
-Family HCC
-PAGE-B score >/= 10

#HBVmastodon #IDmastodon #Medmastodon #TLM22

🔥B-CLEAR published ! «promising»

Next;

➡️B-SURE (ongoing); follow some participants of B-CLEAR for an additional 33 months and includes criteria for ⚠️ NA stop

➡️B-TOGETHER (completed); ➡️HBeAg (-/+) stable NA,+ Bepi 12 or 24w, then pegIFN 24w ✔️Keep NA

➡️B-WELL (starting soon);➡️HBeAg (-) stable NA (HBsAg >100 <3000), + Bepi x24w then ⚠️stop NA

#IDmastodon #TLM22

https://www.nejm.org/doi/full/10.1056/NEJMoa2210027

Having attempted to cover my first medical conference (#TLM22) using both Mastodon & Twitter, I can see the former isn't suited to this type of live coverage. Too slow & too cumbersome. On the other hand, Twitter remains fine for this. You can follow conference hashtags & not see any hint of politics, hate speech, or Musk's latest antics. It requires extra "infrastructure" cost (mainly my time) to use multiple platforms, but I think I'll stick with "different tools for different jobs."

#HBVtwitter #IDtwitter
#TLM22 #IDMastodon (?)

🆕AASLD guidance for HCC screening

➡️Ultrasound + AFP q6months

✔️Cirrhosis (any etiology, including HCV post-SVR)

✔️Non-cirrhotic HBV:
-Man from endemic country >40y
-Woman from endemic country >50y
-Person from Africa at earlier age
-Family HCC
-PAGE-B score >/= 10

Mainstream media & Twitter pundits may have moved on from this summer's mystery #PediatricHepatitis outbreak, but some of us are still paying attention. International repository collected data on 151 cases from 25 counties through 10/28/22. Cases peaked in May-June. About 3% of the children were immunocompromised, 10% (15 kids) were known to have had SARS-CoV-2 in past year, only 13% (20 kids) had received COVID vaccines (many were too young to be eligible). #LiverMtg22 #TLM22

After the remarkable success curing #hepatitisC, the repeated disappointments with #hepatitisB (& #NAFLD/NASH) are frustrating! @AASLDtweets@twitter.com #LiverMtg22 #TLM22

RT @JMPawlotsky@twitter.com

Must read ! My Viewpoint on "New hepatitis B drug development disillusions: time to reset?" just online in The Lancet Gastroenterology and Hepatology, at the following link: http://shorturl.at/otuvP. #TLM22 @LancetGastroHep@twitter.com @HepatologyHugh@twitter.com @AASLDtweets@twitter.com @EASLnews@twitter.com @HepBFoundation@twitter.com

🐦🔗: https://twitter.com/JMPawlotsky/status/1588874633318903808